MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...
Welcome to New Music Friday, your one place to discover the biggest new song and album releases. Doja Cat will be hoping for a third UK Top 5 album with Vie. The LP sees Doja collaborate with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback